Literature DB >> 2171518

Solubilization and partial purification of GABAB receptor from bovine brain.

Y Ohmori1, K Kuriyama.   

Abstract

gamma-Aminobutyric acid (GABA)B receptor has been solubilized and partially purified by an affinity column chromatography. GABAB receptor was solubilized by 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) in the presence of asolectin. The solubilized GABAB receptor was adsorbed on baclofen-coupled epoxy-activated Sepharose 6B. The affinity matrix adsorbed 80% of the solubilized [3H]GABA binding activity to GABAB receptor, and approximately 75% of the adsorbed activity could be eluted with 1 M KC1. GABAB receptor binding in the fraction eluted from affinity column was displaced by GABA, baclofen and 2-hydroxy saclofen in a dose-dependent manner. Furthermore, the purified GABAB receptor showed approximately 2800-fold purification as compared with the original solubilized fraction and possessed the specific binding activity of 17.68 p mol/mg of protein. This binding consisted of a single binding site with a dissociation constant of 64.4 nM. The present results indicate that affinity column chromatographic procedures using baclofen-coupled epoxy-activated Sepharose 6B are suitable for the partial purification of GABAB receptor from cerebral tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171518     DOI: 10.1016/s0006-291x(05)80167-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Pharmacological and biochemical characteristics of partially purified GABAB receptor.

Authors:  Y Ohmori; K Kuriyama
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

2.  Solubilization and characterization of GABAB receptor binding sites from porcine brain synaptic membranes.

Authors:  M Facklam; N G Bowery
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

Review 3.  Cerebral GABAB receptor: proposed mechanisms of action and purification procedures.

Authors:  K Kuriyama; H Nakayasu; H Mizutani; R Narihara; T Ichida
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.